Search - tctmd.com

Displaying 1 - 20 of 26

Sort: Relevancy | Date

News Conference News CX Symposium 2025

Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices

L.A. McKeown

April 23, 2025

News Conference News VIVA 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

L.A. McKeown

November 05, 2024

News Conference News LINC 2023

Early Data on Temporary Spur in BTK PAD Show Efficacy, Limited Recoil

L.A. McKeown

June 09, 2023

News Daily News

Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy

L.A. McKeown

June 01, 2022

Presentation TCT 2021

Role of Drug Eluting Technologies as Definitive Therapy

Presenter: Thomas Zeller

November 06, 2021

News Daily News

Vascular Experts Say It’s Time to Let Paclitaxel Out of Regulatory Jail

L.A. McKeown

April 22, 2021

News Conference News LINC 2020

Algorithm Aims to Help Operators Pair Laser Settings With PAD Lesion Type

L.A. McKeown

February 06, 2020

News Conference News LINC 2020

Common-Femoral Lesions: LINC 2020 Experts Hash Out the Best PAD Treatment

L.A. McKeown

January 31, 2020

Presentation TCT 2019

Sustained Limus Release-Designed Drug-Eluting Balloons: Is This the Solution for the Potential Increased Mortality With Paclitaxel Devices When Treating the SFA?

Presenter: Thomas Zeller

September 27, 2019

Presentation TCT 2019

My Toughest BTK Case of the Year

Presenter: Thomas Zeller

September 25, 2019

Presentation TCT 2019

A Comparison of Multiple Short Stents With Long Stents for Femoral Popliteal Lesions: Results of the LOCOMOTIVE Trial of VascuFlex System (From B. Braun)

Presenter: Thomas Zeller

September 25, 2019

News Industry News

Veryan Medical receives PMA approval for BioMimics 3D

October 05, 2018

Presentation TCT 2017

Long-Term Data With Standard-Dose DCB Technologies (IN.PACT SFA and the Consequent Trial)

Presenter: William A. Gray, Thomas Zeller, Peter A. Schneider

November 01, 2017

Presentation TCT 2017

Multilevel Disease: How Does BTK Disease Affect ATK Therapy?

Presenter: D. Christopher Metzger, Thomas Zeller, Tony Das

October 31, 2017

Presentation TCT 2017

Treating Long, Calcified Lesions, the Achilles Heel for Endovascular Therapy

Presenter: D. Christopher Metzger, Thomas Zeller, Nicolas W Shammas

October 31, 2017

Presentation TCT 2017

Does Lesion Length Affect Treatment Choice in the Fem-pop Segment?

Presenter: D. Christopher Metzger, Thomas Zeller, William A. Gray

October 31, 2017

Presentation TCT 2017

Crossing and Treating Long Lesions: Does the True Lumen Matter for Drug Delivery?

Presenter: D. Christopher Metzger, Thomas Zeller

October 31, 2017

Presentation TCT 2017

Drug Eluting Scaffold With an Absorbable Platform for Primary Lower Extremity Arterial Revascularization DESappear Study Initial Results

Presenter: Tony Das, Thomas Zeller

October 30, 2017

Presentation TCT 2017

Percutaneous Femoropopliteal Bypass Using the Novel PQ Bypass DETOUR Procedure for Long-Segment Disease: Interim Safety and Efficacy Data from the DETOUR I Trial

Presenter: Tony Das, Thomas Zeller, Grzegorz Halena, MD

October 30, 2017

Presentation TCT 2017

The BioMimics 3DTM Stent System in the Femoropopliteal Arteries of Patients With Symptomatic Peripheral Arterial Disease: Clinical and Angiographic Performance in the MIMICS-2 Study

Presenter: Tony Das, Thomas Zeller, Georgios Bouras

October 30, 2017

Advertisement

Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

Early Data on Temporary Spur in BTK PAD Show Efficacy, Limited Recoil

Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy

Role of Drug Eluting Technologies as Definitive Therapy

Vascular Experts Say It’s Time to Let Paclitaxel Out of Regulatory Jail

Algorithm Aims to Help Operators Pair Laser Settings With PAD Lesion Type

Common-Femoral Lesions: LINC 2020 Experts Hash Out the Best PAD Treatment

Sustained Limus Release-Designed Drug-Eluting Balloons: Is This the Solution for the Potential Increased Mortality With Paclitaxel Devices When Treating the SFA?

My Toughest BTK Case of the Year

A Comparison of Multiple Short Stents With Long Stents for Femoral Popliteal Lesions: Results of the LOCOMOTIVE Trial of VascuFlex System (From B. Braun)

Veryan Medical receives PMA approval for BioMimics 3D

Long-Term Data With Standard-Dose DCB Technologies (IN.PACT SFA and the Consequent Trial)

Multilevel Disease: How Does BTK Disease Affect ATK Therapy?

Treating Long, Calcified Lesions, the Achilles Heel for Endovascular Therapy

Does Lesion Length Affect Treatment Choice in the Fem-pop Segment?

Crossing and Treating Long Lesions: Does the True Lumen Matter for Drug Delivery?

Drug Eluting Scaffold With an Absorbable Platform for Primary Lower Extremity Arterial Revascularization DESappear Study Initial Results

Percutaneous Femoropopliteal Bypass Using the Novel PQ Bypass DETOUR Procedure for Long-Segment Disease: Interim Safety and Efficacy Data from the DETOUR I Trial

The BioMimics 3DTM Stent System in the Femoropopliteal Arteries of Patients With Symptomatic Peripheral Arterial Disease: Clinical and Angiographic Performance in the MIMICS-2 Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content